The Hypertension Optimal Treatment Study (The HOT Study)

作者: Hnnsson L

DOI:

关键词: PlaceboOptimal treatmentSurgeryFelodipine 5 MGClinical eventsAspirinLow doseInternal medicineBlood pressureDouble blindMedicine

摘要: The Hypertension Optimal Treatment (HOT) Study is a prospective, randomized, multicenter study which will be conducted in some 20 countries world-wide. Two major issues investigated: i) What the optimal target diastolic blood pressure duringantihypertensive treatment with regard to thereduction cardiovascular morbidity and mortality? In order address this question patients randomized three different therapeutic goals: <90 mmHg, g85 mmHg or < 80 mmHg; ii) second aim evaluate effect of low dose acetylsalicylic acid (ASA, aspirin) 75 mg 0.d. comparison placebo on mortality. first investigated accordance PROBE design (Prospective Randomized Open Blinded Endpoint evaluation), whereas evaluation aspirin versus under double blind conditions. It estimated that 1.100 clinical events needed answer regarding relationship between events. collection these require enrolment at least 18,000 hypertensive men women aged 50-80 years followed for 2.5 (about 40,000 patient years). All given felodipine 5 as basic antihypertensive addition 8-blocker an ACEinhibitor step, further predetermined increments dosage required obtain

参考文章(11)
Salim Yusuf, Richard Peto, John Lewis, Rory Collins, Peter Sleight, Beta blockade during and after myocardial infarction: An overview of the randomized trials Progress in Cardiovascular Diseases. ,vol. 27, pp. 335- 371 ,(1985) , 10.1016/S0033-0620(85)80003-7
JohnM. Cruickshank, JeffreyM. Thorp, F.James Zacharias, BENEFITS AND POTENTIAL HARM OF LOWERING HIGH BLOOD PRESSURE The Lancet. ,vol. 329, pp. 581- 584 ,(1987) , 10.1016/S0140-6736(87)90231-5
R Peto, R Gray, R Collins, K Wheatley, C Hennekens, K Jamrozik, C Warlow, B Hafner, E Thompson, S Norton, J Gilliland, R Doll, Randomised trial of prophylactic daily aspirin in British male doctors BMJ. ,vol. 296, pp. 313- 316 ,(1988) , 10.1136/BMJ.296.6618.313
Christopher G. Isles, Louise M. Walker, Gareth D. Beevers, Irene Brown, Helen L. Cameron, John Clarke, Victor Hawthorne, David Hole, Anthony F. Lever, James W.K. Robertson, Jean A. Wapshaw, Mortality in patients of the Glasgow Blood Pressure Clinic. Journal of Hypertension. ,vol. 4, pp. 141- 156 ,(1986) , 10.1097/00004872-198604000-00003
Michael H Alderman, Wee L Ooi, Shantha Madhavan, Hillel Cohen, Treatment-Induced Blood Pressure Reduction and the Risk of Myocardial Infarction JAMA: The Journal of the American Medical Association. ,vol. 262, pp. 920- 924 ,(1989) , 10.1001/JAMA.1989.03430070068032
Jan Staessen, Robert Fagard, Roger Van Hoof, Antoon Amery, Blood Pressure Reduction and the Risk of Myocardial Infarction JAMA: The Journal of the American Medical Association. ,vol. 263, pp. 660- 661 ,(1990) , 10.1001/JAMA.1990.03440050054025
L. Hansson, What are we really achieving with long-term drug therapy? American Journal of Hypertension. ,vol. 1, pp. 414- 420 ,(1988) , 10.1093/AJH/1.4.414
R Collins, R Peto, S MacMahon, J Godwin, N Qizilbash, R Collins, S MacMahon, P Hebert, K.A Eberlein, J.O Taylor, C.H Hennekens, N.H Fiebach, N Qizilbash, C.H Hennekens, Blood pressure, stroke, and coronary heart disease The Lancet. ,vol. 335, pp. 827- 838 ,(1990) , 10.1016/0140-6736(90)90944-Z
Stephen Macmahon, The effects of antihypertensive drug treatment on the incidence of stroke and of coronary heart disease. Clinical and Experimental Hypertension. ,vol. 11, pp. 807- 823 ,(1989) , 10.3109/10641968909035375